Ömer F. Karataş and M. Ittmann, “MiR-33a and statins collaboratively reduce the proliferative capacity of prostate cancer cells”, Eur Res J, vol. 4, no. 4, pp. 266–274, Oct. 2018, doi: 10.18621/eurj.380619.